kokonut
New Member
- Joined
- Jul 9, 2006
- Messages
- 16,006
- Reaction score
- 2
First FDA-Approved Study of Stem Cells to Treat Hearing Loss Begins at ChildrenChildren’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
The study, which will use patients’ stem cells from their own stored umbilical cord blood, is the first-of-its-kind, and has the potential to restore hearing. This follows evidence from published laboratory studies that cord blood helps repair damaged organs in the inner ear.
The year-long study will follow 10 children, ages 6 weeks to 18 months, who have sustained post-birth hearing loss. Children who are deaf as a result of a genetic anomaly or syndrome are not eligible. To ensure consistency in cord blood stem cell processing, storage, and release for infusion, CBR is the only stem cell bank providing clients for the study.
.
.
.
Researchers will obtain and process the patients’ stored cord blood for treatment. The cells then will be given to the patients via IV infusion, and patients will be observed for several hours in the hospital.
Patients will return to the hospital to repeat all tests except the MRI at one month and one year, and all tests with an MRI at six months.
“This study is exciting because it might offer a non-surgical option for some children with profound loss,” Linda Baumgartner said. “More importantly, this is the first treatment with the potential to restore normal hearing.”
Wow. Well, that's coming in a lot sooner than expected of all places, the United States in the restoration of nerve deafness in children. This is the first of its kind here. All done naturally, too, using the children's own stem cells from their own cord blood. It'll be interesting to read up on the results in 2013 or 2014. Looking forward to it.
Last edited: